1. Home
  2. Bills
  3. H.R. 9661

H.R. 9661 · 119th Congress · 2025–2026

Expedited Access to Biosimilars Act

H.R. 9661 in the 119th Congress (2025–2026) was introduced on Jul 14, 2026, sponsored by Nicholas A. Langworthy with 2 co-sponsors.

During the 119th Congress (2025–2026), Donald Trump was president, and Republicans held majorities in both the House and Senate.

Status
Introduced
Introduced
Jul 14, 2026
Co-sponsors
2
Policy area
Health

Sponsor

Nicholas A. Langworthy (R-NY). Co-sponsors: 1 Democrat, 1 Republican.

Where it stands

  • IntroducedJul 14, 2026
  • Passed the House—
  • Passed the Senate—
  • Sent to the President—
  • Became law—

Latest action: Referred to the House Committee on Energy and Commerce. (Jul 14, 2026)

More bills from Nicholas A. Langworthy in the 119th Congress

Other Health bills in the 119th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “H.R. 9661 (119th Congress): Expedited Access to Biosimilars Act,” https://www.capitolreceipts.com/bill/119-hr-9661/expedited-access-to-biosimilars-act (accessed 2026-10-15).

Open the interactive version ›